Senescence was not induced in NrasQ61 melanoma cell lines by palbociclib as NrasQ61 mutant activates both MAPK signaling and PI3K-mTOR pathway and we previously demonstrated that mTORC1 signaling activation is the resistance mechanism to CDK4/6i [26]. The gene discussed is MTOR; the disease is melanoma.